PEN | PenumbraNYSEHealthcareCommon stock golden cross and death cross projections, cross tests and history

$320.02
-$1.32 (-0.41%)

Penumbra (PEN) is a NYSE-listed common stock that Cruxta has tracked for 50/200 crosses since 2018.

The 50 SMA has sat below the 200 on the daily since Aug 2026, with no cross projected inside the 30 bars Cruxta tracks. On both the daily and the 4-hour, price sits below the 50 and the 200; on the weekly it is between the two.

Timeframe summary

Daily as of 3 Nov 16:00 ET

Price
below both $320.02 vs 50 $320.35 / 200 $327.19
Projection
No cross projected
Test
No active test
Last cross
Death cross 17 Aug 2026 ยท projected 26 bars out ยท tested 1 bar

Weekly as of 30 Oct 16:00 ET

Price
between the two $318.95 vs 50 $324.40 / 200 $266.87
Projection
No cross projected
Test
No active test
Last cross
Golden cross week of 12 May 2025 ยท projected 22 bars out ยท tested 1 bar

4-hour as of 3 Nov 16:00 ET

Price
below both $320.02 vs 50 $320.58 / 200 $320.35
Projection
Death cross estimated in 20 to 29 bars
Test
No active test
Last cross
Golden cross 28 Oct 2026 bar 1 ยท projected 27 bars out ยท tested 5 bars

Cross history

29
crosses on record since 2018
14 golden15 death
Full cross history โ†’
CrossedDirectionTimeframeProjectedCross test
28 Oct 2026Golden4-hour27 bars out5 bar cross test
24 Sep 2026Death4-hour30 bars outNot tested
24 Aug 2026Golden4-hour30 bars out3 bar cross test
17 Aug 2026Death flatdaily26 bars out1 bar cross test
29 Apr 2026Death4-hour19 bars outNot tested

About PEN

ExchangeNYSE
InstrumentCommon stock
Median $ volume, 60 d$95.7M
4-hour coverageYes, since Oct 2025
History on recordSince 2018
SectorHealthcare
Cap bandlarge

Cruxta · 50/200 moving-average crosses on US equities. Recorded crosses are observations. Projected crosses are projections, not advice.